Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.

Neal Thomas1

  • 1Statistical Research and Consulting Center, Pfizer Inc, New London, Connecticut 06230, USA. neal.thomas@pfizer.com

Journal of Biopharmaceutical Statistics
|October 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive review and shiny application on the matching-adjusted indirect comparison.

Research synthesis methods·2024
Same author

Pediatric Critical Care-Associated Parental Traumatic Stress: Beyond the First Year.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2023
Same author

Practice Patterns of Central Venous Catheter Placement and Confirmation in Pediatric Critical Care.

Journal of pediatric intensive care·2022
Same author

Pediatric Organ Dysfunction Information Update Mandate (PODIUM) Contemporary Organ Dysfunction Criteria: Executive Summary.

Pediatrics·2021
Same author

Estimating adjusted risk differences by multiply-imputing missing control binary potential outcomes following propensity score-matching.

Statistics in medicine·2021
Same author

Evaluating the Utility of Toxicologic Analysis in Pediatric Out-of-Hospital Cardiac Arrest.

The Journal of emergency medicine·2020
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces a sigmoid Emax model for dose-response assessment with limited doses. It uses Bayesian methods for robust estimation, improving uncertainty handling in drug development.

Area of Science:

  • Pharmacometrics
  • Statistical modeling in drug development

Background:

  • Dose-response assessment is crucial in drug development.
  • Traditional models struggle with sparse data (3-6 doses).
  • Existing methods may miss uncertainty in model selection and parameter estimation.

Purpose of the Study:

  • To present a sigmoid Emax model for dose-response assessment with sparse designs.
  • To evaluate the model's performance using established statistical strategies.
  • To employ Bayesian methods for improved dose-response curve estimation and uncertainty quantification.

Main Methods:

  • Application of a sigmoid Emax model with power (Hill) parameter and ED50.
  • Evaluation strategy following Bretz et al. (2005).
  • Use of multiple comparison methods for alpha control.

Related Experiment Videos

  • Bayesian estimation for dose-response curve fitting with sparse data.

    • Main Results:

    • The sigmoid Emax model provides high power to detect trends from placebo.
    • Multiple comparison methods effectively control the alpha level for no dose-response.
    • Bayesian estimation accurately models dose-response curves from sparse data.
    • Bayesian approach addresses limitations of maximum likelihood estimation with poorly determined parameters.

    Conclusions:

    • The sigmoid Emax model is effective for dose-response assessment in sparse designs.
    • Bayesian estimation enhances the reliability of dose-response modeling by capturing uncertainty.
    • This approach improves statistical rigor in early-phase drug development and sparse data scenarios.